亚组

研究数量

总样本量

患病率

HPD

总的

141

1,218,241

27.61%

(25.79%~29.48%)

性别

男性

117

482,329

31.63%

(29.71%~33.57%)

女性

117

352,950

19.02%

(17.01%~21.19%)

年龄

男

20~29

37

25,656

21.75%

(18.49%~25.25%)

30~39

38

40,030

34.78%

(30.80%~39.00%)

40~49

42

57,107

36.94%

(33.19%~40.76%)

50~59

42

45,775

36.82%

(33.57%~40.13%)

60~69

35

26,973

29.17%

(25.89%~32.66%)

≥70

25

9444

23.40%

(20.05%~27.00%)

女

20~29

35

22,876

4.58%

(3.31%~6.11%)

30~39

37

34,277

9.32%

(7.36%~11.59%)

40~49

41

37,949

15.24%

(13.20%~17.46%)

50~59

41

29,497

26.88%

(23.28%~30.69%)

60~69

36

21,643

32.29%

(28.02%~36.80%)

≥70

25

6742

27.51%

(22.91%~32.50%)

BMI

<18.5

20

8480

3.54%

(1.73%~6.22%)

18.5~23.9

37

111,679

11.52%

(8.94%~14.57%)

24~27.9

41

116,759

38.56%

(34.50%~42.74%)

≥28

55

72,203

60.82%

(55.65%~65.81%)

血糖水平

正常血糖

10

23,050

23.77%

(16.02%~33.13%)

血糖受损

9

6461

43.18%

(36.93%~49.68%)

糖尿病

65

61,568

51.64%

(48.08%~55.15%)

MS患者

18

12,095

60.70%

(52.73%~68.36%)

HLP患者

33

75,830

44.13%

(39.92%~48.50%)

合并

超重

40

103,815

48.35%

(44.59%~52.14%)

肥胖

58

125,731

45.55%

(36.91%~54.53%)

糖尿病

64

128,687

22.68%

(19.14%~26.59%)

MS

22

22,738

43.62%

(36.69%~50.82%)

HLP

34

56,394

65.61%

(59.95%~71.02%)